FI70898C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla dibensoimidazo-azepiner -oxazepiner och -tiazepiner - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla dibensoimidazo-azepiner -oxazepiner och -tiazepiner Download PDF

Info

Publication number
FI70898C
FI70898C FI810712A FI810712A FI70898C FI 70898 C FI70898 C FI 70898C FI 810712 A FI810712 A FI 810712A FI 810712 A FI810712 A FI 810712A FI 70898 C FI70898 C FI 70898C
Authority
FI
Finland
Prior art keywords
formula
dibenz
dihydro
halogen
compounds
Prior art date
Application number
FI810712A
Other languages
English (en)
Finnish (fi)
Other versions
FI810712L (fi
FI70898B (fi
Inventor
Gerhard Walther
Claus S Schneider
Karl-Heinz Weber
Armin Fuegner
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI810712L publication Critical patent/FI810712L/fi
Publication of FI70898B publication Critical patent/FI70898B/fi
Application granted granted Critical
Publication of FI70898C publication Critical patent/FI70898C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20[b, f]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16[b, f]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI810712A 1980-03-08 1981-03-06 Foerfarande foer framstaellning av farmakologiskt vaerdefulla dibensoimidazo-azepiner -oxazepiner och -tiazepiner FI70898C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803008944 DE3008944A1 (de) 1980-03-08 1980-03-08 Dibenzimidazoazepine, ihre herstellung und verwendung
DE3008944 1980-03-08

Publications (3)

Publication Number Publication Date
FI810712L FI810712L (fi) 1981-09-09
FI70898B FI70898B (fi) 1986-07-18
FI70898C true FI70898C (fi) 1986-10-27

Family

ID=6096617

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810712A FI70898C (fi) 1980-03-08 1981-03-06 Foerfarande foer framstaellning av farmakologiskt vaerdefulla dibensoimidazo-azepiner -oxazepiner och -tiazepiner

Country Status (29)

Country Link
US (1) US4313931A (nl)
EP (1) EP0035749B1 (nl)
JP (1) JPS56139484A (nl)
AU (1) AU535359B2 (nl)
BG (1) BG33886A3 (nl)
CA (1) CA1150253A (nl)
CS (2) CS221288B2 (nl)
DD (1) DD156708A5 (nl)
DE (2) DE3008944A1 (nl)
DK (1) DK154299C (nl)
ES (1) ES8301481A1 (nl)
FI (1) FI70898C (nl)
GB (1) GB2071095B (nl)
GR (1) GR74805B (nl)
HK (1) HK63186A (nl)
HU (1) HU180628B (nl)
IE (1) IE51015B1 (nl)
IL (1) IL62309A (nl)
MX (1) MX6869E (nl)
NO (1) NO162073C (nl)
NZ (1) NZ196446A (nl)
PH (1) PH15839A (nl)
PL (1) PL132141B1 (nl)
PT (1) PT72631B (nl)
RO (1) RO81652B (nl)
SU (1) SU1015829A3 (nl)
UA (1) UA8041A1 (nl)
YU (1) YU42557B (nl)
ZA (1) ZA811500B (nl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134672A1 (de) * 1981-09-02 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Heterocyclische verbindungen, ihre herstellung und verwendung
JPS60500176A (ja) * 1982-12-30 1985-02-07 ビ−チヤム グル−プ ピ−エルシ− 四環式化合物
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
US7196193B2 (en) * 2002-04-11 2007-03-27 Konica Minolta Chemical Co., Ltd. Method for preparing 6-aminomethyl-6, 11-dihydro-5h-dibenz[b,e]azepine
JP4514017B2 (ja) * 2003-03-27 2010-07-28 大日本印刷株式会社 塩酸エピナスチンの製造方法
WO2006058022A1 (en) 2004-11-24 2006-06-01 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
EP1901724A1 (en) * 2005-07-08 2008-03-26 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising epinastine
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13b디하이드로-1H-디벤즈-[c,f]이미다조[1,5-a]-아제핀 염산염의 제조방법
WO2009063504A2 (en) * 2007-09-24 2009-05-22 Usv Limited Novel crystal modification of epinastine or salts thereof and process for preparation thereof
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
JP2010120960A (ja) * 2010-02-17 2010-06-03 Dainippon Printing Co Ltd 塩酸エピナスチンの製造方法
JP6006634B2 (ja) * 2011-12-28 2016-10-12 東和薬品株式会社 イソウレア化合物を用いるエピナスチンの製造方法
CN103172638B (zh) * 2013-03-13 2015-09-16 北京朗依制药有限公司 一种盐酸依匹斯汀的制备方法
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
KR102041389B1 (ko) * 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
KR102080239B1 (ko) 2019-08-06 2020-02-21 한양대학교 에리카산학협력단 에피나스틴의 신규 제조방법
CN115974882A (zh) * 2023-02-08 2023-04-18 广州艾格生物科技有限公司 一种盐酸依匹斯汀杂质的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789410A (fr) * 1971-10-05 1973-01-15 Akzo Nv Nieuwe imidazolidine derivaten
NL7202963A (nl) * 1972-03-07 1973-09-11
NL7414038A (nl) * 1974-10-28 1976-05-03 Akzo Nv Nieuwe tetracyclische pyrrolidino derivaten.

Also Published As

Publication number Publication date
PT72631B (fr) 1982-12-30
DK103581A (da) 1981-09-09
HU180628B (en) 1983-03-28
JPH0366311B2 (nl) 1991-10-16
YU56881A (en) 1983-10-31
IE810485L (en) 1981-09-08
DE3163938D1 (en) 1984-07-12
PT72631A (fr) 1981-04-01
NO810762L (no) 1981-09-09
US4313931A (en) 1982-02-02
PH15839A (en) 1983-04-08
GB2071095A (en) 1981-09-16
PL132141B1 (en) 1985-02-28
IL62309A (en) 1984-06-29
NO162073C (no) 1989-11-01
MX6869E (es) 1986-09-11
DK154299C (da) 1989-03-28
NO162073B (no) 1989-07-24
AU535359B2 (en) 1984-03-15
CA1150253A (en) 1983-07-19
ZA811500B (en) 1982-11-24
FI810712L (fi) 1981-09-09
RO81652A (ro) 1983-04-29
GB2071095B (en) 1983-06-02
GR74805B (nl) 1984-07-12
IE51015B1 (en) 1986-09-03
ES500150A0 (es) 1982-12-01
BG33886A3 (en) 1983-05-16
FI70898B (fi) 1986-07-18
JPS56139484A (en) 1981-10-30
RO81652B (ro) 1983-04-30
DK154299B (da) 1988-10-31
NZ196446A (en) 1984-07-06
ES8301481A1 (es) 1982-12-01
EP0035749A1 (de) 1981-09-16
PL230036A1 (nl) 1982-05-24
YU42557B (en) 1988-10-31
AU6815881A (en) 1981-09-17
CS410491A3 (en) 1992-05-13
CS221288B2 (en) 1983-04-29
EP0035749B1 (de) 1984-06-06
IL62309A0 (en) 1981-05-20
UA8041A1 (uk) 1995-12-26
HK63186A (en) 1986-09-05
DE3008944A1 (de) 1981-09-24
DD156708A5 (de) 1982-09-15
SU1015829A3 (ru) 1983-04-30

Similar Documents

Publication Publication Date Title
FI70898B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla dibensoimidazo-azepiner -oxazepiner och -tiazepiner
SK33995A3 (en) Imidazodiazepines
IE42737B1 (en) Substituted 6-aryl-4h-s-triazolo /3,4c/ thieno -/2,3e/ -1,4-diazepines and acid addition salts thereof
FI76089B (fi) Foerfarande foer framstaellning av farmakologiskt verkande 3-imino-2,3-dihydro-dibenso/c,f/imidazo/1,5-a/ azepiner och -dibens/b,f/imidazo/1,5-d/okazepiner och -tiazepiner.
IL95321A (en) 4-Transformed History of G-) H] -014- Phnothiazine-01-Il (Alkyl [-2-Oxo-1-Oxa-8-Azaspiro] 4,5 [Decan, Preparation and Pharmaceutical Preparations Containing Them
DK141289B (da) Analogifremgangsmåde til fremstilling af epimere blandinger eller individuelle epimere af bicykliske imidazoler eller pyrimidiner, eller syreadditionssalte deraf.
SK1052000A3 (en) 3-substituted 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]thieno[2,3-d] pyrimidine derivatives, their preparation and use as 5ht antagonists
US3763142A (en) Thiazolodiazepines
US3962222A (en) 3A,4,6,7-Tetrahydro-3-phenyl-7-(phenylalkylene)-thiopyrano[4,3-C]pyrazole-2(3H)-alkanamine, and analogs
US3755300A (en) Process for the preparation of benzodiazepine compounds
FI84825C (fi) Foerfarande foer framstaellning av piperazin-1-ylergolinderivat.
FI62086B (fi) Foerfarande foer framstaellning av bronkosekreterolytiska 5,11-dihydro-5h-pyrido-(2,3-b)(1,5)bensodiazepin-5-oner
CA2020297A1 (en) 4h-indolo [1,2-d](1,2,4]triazolo[4,3-a](1,4)benzodiazepines, a process for their preparation and their use as medicaments
CS220336B2 (en) Method of producing new guanidine derivatives
US4028356A (en) Triazinobenzodiazepines
US4016165A (en) Triazino benzodiazepines
KR850000173B1 (ko) 사이클릭 구아니딘 유도체의 제조방법
US3892763A (en) 1-Propynylaminomethyl-6-phenyl-4H-s-triazolo{8 4,3-a{9 {8 1,4{9 benzodiazepines
CA2415475C (en) Pyrrolo[2,1-b][1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity
NZ202714A (en) 5-diazacycloalkyl-imidazo(1,2-c)(1,3)benzodiazepine derivatives,a method for their preparation and pharmaceutical preparations
PL147855B1 (en) Method of obtaining aromatic 1,4-oxazepinones and thiones
PL115061B1 (en) Process for preparing novel substituted 1-piperazinylo-4h-sym-triazolo/3,4-c/thieno/2,3-e/-1,4-diazepins
SI8110568A8 (sl) Postopek za pripravo novih dibenzimidazoazepinov
PL138859B1 (en) Method of obtaining novel phenyl substituted pyrido /1,4/ benzosiazepins

Legal Events

Date Code Title Description
MA Patent expired

Owner name: C.H. BOEHRINGER SOHN